FMG1021 生物

home > TISSUE ARRAYS > Breast > FMG1021

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone_Cartilage
- Oral_Cavity
- Bone_Marrow
- Heart
- Spleen
- Head_Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

102

CASES:

102

Core Diameter(mm):

1

Thickness(µm):

5

Row number:

8

Column number:

13

Tissue Array Type:

FFPE

Species:

Human

FMG1021

$212.00

Description: Multiple types breast cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 102 cases/102 cores

Details: Multiple types breast carcinoma tissue microarray with adjacent normal tissue, containing 69 cases of invasive carcinoma of no special type, 4 mixed cancer, 11 each of lobular carcinoma and medullary carcinoma, 2 apocrine carcinoma, 5 adjacent normal breast tissue, single cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

102 Cores 102 Cases Breast Matched or Unmatched special price single core per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Malignant(*)
Malignant(IIA)
Malignant(IIB)
Malignant(IIIA)
Malignant(IIIB)
Malignant(IV)
NAT(*)

TISSUE ARRAYS
FMG1021

	1	2	3	4	5	6	7	8	9	10	11	12	13
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre

FMG1021

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Tumor size	ER	Her-2
A1	1	75	F	Breast	Invasive carcinoma of no special type	1	T3N1M0	IIIA	Malignant	544	+++，100%	0
A2	2	43	F	Breast	Invasive carcinoma of no special type (sparse)	1	T3N0M0	IIB	Malignant	5*3	-	3
A3	3	51	F	Breast	Invasive carcinoma of no special type	1	T2N2M0	IIIA	Malignant	3*3	+++，100%	0
A4	4	32	F	Breast	Invasive carcinoma of no special type	1--2	T3N1M0	IIIA	Malignant	653	+，40%	0
A5	5	55	F	Breast	Invasive carcinoma of no special type (sparse)	1--2	T4N1M0	IIIB	Malignant	332.5	-	3
A6	6	55	F	Breast	Invasive carcinoma of no special type	1--2	T2N2M0	IIIA	Malignant	*	-	3
A7	7	54	F	Breast	Invasive carcinoma of no special type with necrosis	2	T3N0M0	IIB	Malignant	332.5	-	2
A8	8	48	F	Breast	Invasive carcinoma of no special type	2	T3N0M0	IIB	Malignant	752.5	+++，90%	0
A9	9	30	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	3.52.51	+++，95%	0
A10	10	38	F	Breast	Invasive carcinoma of no special type (sparse)	2	T3N0M0	IIB	Malignant	5*4	+++，80%	0
A11	11	87	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	6*4	-	0
A12	12	44	F	Breast	Invasive carcinoma of no special type (breast tissue)	*	T2N2M0	IIIA	Malignant	2.511	+	0
A13	13	31	F	Breast	Invasive carcinoma of no special type	2	T4N2M0	IIIB	Malignant	*	+++，80%	0
B1	14	42	F	Breast	Invasive carcinoma of no special type	2	T4N2M0	IIIB	Malignant	662	-	0
B2	15	55	F	Breast	Invasive carcinoma of no special type	2	T3N2M0	IIIA	Malignant	*	+++，90%	0
B3	16	37	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	2.522	-	0
B4	17	37	F	Breast	Invasive carcinoma of no special type	2	T2N2M0	IIIA	Malignant	532	+++，100%	0
B5	18	48	F	Breast	Invasive carcinoma of no special type	2	T2N2M0	IIIA	Malignant	2*2	++，80%	0
B6	19	48	F	Breast	Invasive carcinoma of no special type (sparse)	2	T1N1M0	IIA	Malignant	3.522	++，90%	0
B7	20	46	F	Breast	Invasive carcinoma of no special type	2	T3N2M0	IIIA	Malignant	9*5	-	3
B8	21	68	F	Breast	Invasive carcinoma of no special type	2	T3N0M0	IIB	Malignant	11*6	+，80%	0
B9	22	41	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	5*2.2	+++，100%	0
B10	23	42	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	654	-	0
B11	24	47	F	Breast	Invasive carcinoma of no special type	2	T4N1M0	IIIB	Malignant	2.522	+++，95%	0
B12	25	32	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	5*3	-	1
B13	26	52	F	Breast	Invasive carcinoma of no special type (sparse)	2	T2N1M0	IIB	Malignant	2*2	-	0
C1	27	54	F	Breast	Invasive carcinoma of no special type	2	T2N1M0	IIB	Malignant	32.51	+,30%	0
C2	28	29	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	*	-	2
C3	29	53	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	*	+++,95%	0
C4	30	32	F	Breast	Invasive carcinoma of no special type	2	T4N1M0	IIIB	Malignant	533	+,35%	2
C5	31	36	F	Breast	Invasive carcinoma of no special type (breast tissue)	*	T2N0M0	IIA	Malignant	*	*	0
C6	32	35	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	*	-	0
C7	33	34	F	Breast	Invasive carcinoma of no special type	2	*	*	Malignant	*	++，85%	0
C8	34	51	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	*	-	1
C9	35	49	F	Breast	Invasive carcinoma of no special type	2	T2N0M0	IIA	Malignant	*	+++，90%	0
C10	36	52	F	Breast	Invasive carcinoma of no special type	2	T3N1M0	IIIA	Malignant	5*4.5	+，15%	0
C11	37	30	F	Breast	Invasive carcinoma of no special type	2	T3N0M0	IIB	Malignant	*	-	0
C12	38	61	F	Breast	Invasive carcinoma of no special type	2	T3N1M0	IIIA	Malignant	43.52	+++，100%	3
C13	39	59	F	Breast	Invasive carcinoma of no special type	2	*	*	Malignant	*	+，15%	3
D1	40	53	F	Breast	Invasive carcinoma of no special type	2--3	T2N2M0	IIIA	Malignant	432	-	0
D2	41	42	F	Breast	Invasive carcinoma of no special type	2--3	T2N1M0	IIB	Malignant	542.5	++，60%	0
D3	42	59	F	Breast	Invasive carcinoma of no special type	2--3	T2N0M0	IIA	Malignant	64.53	-	0
D4	43	45	F	Breast	Invasive carcinoma of no special type	2--3	*	*	Malignant	*	+++，100%	0
D5	44	49	F	Breast	Invasive carcinoma of no special type	2--3	*	*	Malignant	*	-	2
D6	45	50	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant	4*3.2	+++，100%	0
D7	46	44	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	2.5*2	+++，95%	1
D8	47	48	F	Breast	Invasive carcinoma of no special type	3	T4N2M0	IIIB	Malignant	8.542.6	+++，95%	0
D9	48	38	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant	*	-	0
D10	49	73	F	Breast	Invasive carcinoma of no special type	3	T4N0M0	IIIB	Malignant	653.5	-	3
D11	50	39	F	Breast	Invasive carcinoma of no special type	3	T4N2M0	IIIB	Malignant	7*4	-	0
D12	51	60	F	Breast	Invasive carcinoma of no special type with necrosis	3	T2N2M0	IIIA	Malignant	20*13	-	3
D13	52	55	F	Breast	Invasive carcinoma of no special type	3	T3N0M0	IIB	Malignant	1.5	-	0
E1	53	48	F	Breast	Invasive carcinoma of no special type with necrosis	3	T3N0M0	IIB	Malignant	3*2.3	-	0
E2	54	52	F	Breast	Invasive carcinoma of no special type	3	T1N1M0	IIA	Malignant	43.51	++，90%	0
E3	55	71	F	Breast	Invasive carcinoma of no special type	3	T2N1M0	IIB	Malignant	443.5	-	0
E4	56	56	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	*	++，40%	2
E5	57	40	F	Breast	Invasive carcinoma of no special type (breast tissue)	*	T2N1M0	IIB	Malignant	331	-	0
E6	58	48	F	Breast	Invasive carcinoma of no special type	3	*	*	Malignant	32.51	+，40%	0
E7	59	43	F	Breast	Invasive carcinoma of no special type	3	T1N1M0	IIA	Malignant	32.52	+++，95%	0
E8	60	56	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	*	-	1
E9	61	54	F	Breast	Invasive carcinoma of no special type	3	T2N2M0	IIIA	Malignant	*	-	0
E10	62	52	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant	*	+++，90%	0
E11	63	50	F	Breast	Invasive carcinoma of no special type	3	T2N1M0	IIB	Malignant	54.53	-	0
E12	64	38	F	Breast	Invasive carcinoma of no special type (sparse)	3	T3N1M0	IIIA	Malignant	4.542.5	-	0
E13	65	38	F	Breast	Invasive carcinoma of no special type	3	T2N0M0	IIA	Malignant	3.53.52	-	0
F1	66	37	F	Breast	Invasive carcinoma of no special type with necrosis	3	T3N0M0	IIB	Malignant	4.5*2	-	0
F2	67	40	F	Breast	Invasive carcinoma of no special type	3	*	*	Malignant	*	++，40%	0
F3	68	52	F	Breast	Invasive carcinoma of no special type	3	T4N1M0	IIIB	Malignant	7*3	-	3
F4	69	49	F	Breast	Invasive carcinoma of no special type (interstitial)	*	T2N2M0	IIIA	Malignant	*	-	0
F5	70	47	F	Breast	Lobular-ductal mixed carcinoma	*	T2N1M0	IIB	Malignant	*	+++，95%	0
F6	71	69	F	Breast	Lobular-ductal mixed carcinoma	*	T2N0M0	IIA	Malignant	*	+，50%	0
F7	72	45	F	Breast	Lobular-ductal mixed carcinoma	*	T2N1M0	IIB	Malignant	3.532	+，60%	0
F8	73	41	F	Breast	Lobular-ductal mixed carcinoma	*	T4N0M0	IIIB	Malignant	*	-	0
F9	74	54	F	Breast	Invasive lobular carcinoma	*	T2N1M0	IIB	Malignant	43.52	++，65%	0
F10	75	52	F	Breast	Invasive lobular carcinoma	*	T2N1M0	IIB	Malignant	*	-	0
F11	76	50	F	Breast	Invasive lobular carcinoma	*	T2N2M0	IIIA	Malignant	*	+，15%	0
F12	77	59	F	Breast	Invasive lobular carcinoma	*	T2N0M0	IIA	Malignant	*	++，80%	0
F13	78	43	F	Breast	Invasive lobular carcinoma (sparse)	*	T2N0M0	IIA	Malignant	*	+++，95%	0
G1	79	53	F	Breast	Invasive lobular carcinoma	*	T4N1M0	IIIB	Malignant	*	+++，95%	0
G2	80	50	F	Breast	Invasive lobular carcinoma	*	T2N0M0	IIA	Malignant	*	+++，95%	0
G3	81	42	F	Breast	Invasive lobular carcinoma	*	T3N0M0	IIB	Malignant	*	-	2
G4	82	49	F	Breast	Invasive lobular carcinoma (sparse)	*	T4N0M0	IIIB	Malignant	*	-	0
G5	83	35	F	Breast	Invasive lobular carcinoma	*	T3N0M0	IIB	Malignant	*	+++，95%	0
G6	84	47	F	Breast	Invasive lobular carcinoma	*	T2N0M0	IIA	Malignant	*	+++，80%	0
G7	85	32	F	Breast	Medullary carcinoma	*	T2N1M1	IV	Malignant	*	-	0
G8	86	29	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant	*	+，25%	0
G9	87	45	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant	*	-	0
G10	88	47	F	Breast	Medullary carcinoma (sparse)	*	T2N0M0	IIA	Malignant	*	-	0
G11	89	58	F	Breast	Medullary carcinoma	*	T3N0M0	IIB	Malignant	*	+，30%	0
G12	90	46	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant	*	+，60%	0
G13	91	55	F	Breast	Medullary carcinoma	*	T2N0M0	IIA	Malignant	*	+，2%	0
H1	92	49	F	Breast	Medullary carcinoma	*	T2N2M0	IIIA	Malignant	*	-	0
H2	93	45	F	Breast	Medullary carcinoma	*	T3N0M0	IIB	Malignant	*	-	0
H3	94	47	F	Breast	Medullary carcinoma	*	T2N2M0	IIIA	Malignant	*	-	0
H4	95	60	F	Breast	Medullary carcinoma	*	T3N2M0	IIIA	Malignant	*	-	0
H5	96	44	F	Breast	Apocrine carcinoma with necrosis	*	T3N0M0	IIB	Malignant	*	-	0
H6	97	49	F	Breast	Apocrine carcinoma with necrosis	*	T2N0M0	IIA	Malignant	*	-	0
H7	98	49	F	Breast	Adjacent normal breast tissue	*	*	*	NAT	*	N，+，15%	0
H8	99	58	F	Breast	Adjacent normal breast tissue	*	*	*	NAT	*	N，+，20%	0
H9	100	45	F	Breast	Adjacent normal breast tissue	*	*	*	NAT	*	N，+++，40%	0
H10	101	49	F	Breast	Adjacent normal breast tissue	*	*	*	NAT	*	N,+++，30%	0
H11	102	43	F	Breast	Adjacent normal breast tissue	*	*	*	NAT	*	N，+，15%	0

Find overlapping cases with this tissue array:

FMG1021

File Format: .xlsx

Release Date: 2025-06-30 15:56:43
Download

	1	2	3	4	5	6	7	8	9	10	11	12	13
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre

	1	2	3	4	5	6	7	8	9	10	11	12	13
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre

	1	2	3	4	5	6	7	8	9	10	11	12	13
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre